▶ 調査レポート

鳥インフルエンザワクチンの世界市場レポート2020

• 英文タイトル:Global Avian Influenza Vaccines Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。鳥インフルエンザワクチンの世界市場レポート2020 / Global Avian Influenza Vaccines Sales Market Report 2020 / 20QY06-07408資料のイメージです。• レポートコード:20QY06-07408
• 出版社/出版日:QYResearch / 2020年6月3日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、130ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、鳥インフルエンザワクチンのグローバル市場について種類別(H5型、H9型、その他)、用途別(鶏肉、鴨肉及びガチョウ、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・鳥インフルエンザワクチン市場の概要
・世界の主要地域別鳥インフルエンザワクチン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の鳥インフルエンザワクチン市場規模2015-2026:種類別(H5型、H9型、その他)
・世界の鳥インフルエンザワクチン市場規模2015-2026:用途別(鶏肉、鴨肉及びガチョウ、その他)
・鳥インフルエンザワクチンの北米市場規模2015-2020
・鳥インフルエンザワクチンのヨーロッパ市場規模2015-2020
・鳥インフルエンザワクチンの中国市場規模2015-2020
・鳥インフルエンザワクチンの日本市場規模2015-2020
・鳥インフルエンザワクチンの東南アジア市場規模2015-2020
・鳥インフルエンザワクチンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(Merial、、CEVA、、Zoetis、、Elanco (Lohmann )、、Merck Animal Health、、Avimex Animal Health、)
・鳥インフルエンザワクチンの製造コスト分析
・販売チャネル、流通業者、顧客
・鳥インフルエンザワクチンの市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Avian Influenza Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Avian Influenza Vaccines market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.

QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.

Report Overview:

Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Avian Influenza Vaccines market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the Avian Influenza Vaccines industry.

Based on our recent survey, we have several different scenarios about the Avian Influenza Vaccines YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 108.7 million in 2019. The market size of Avian Influenza Vaccines will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

QY Research report provides an overview and scope of the global Avian Influenza Vaccines market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Avian Influenza Vaccines market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.

QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Avian Influenza Vaccines market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Avian Influenza Vaccines market. The report also includes nautical information, where it shows Avian Influenza Vaccines market product volume, utilization value, and production processes.

The research report also consists of a competitive landscape that describes the top players that are functioning in the global Avian Influenza Vaccines market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Avian Influenza Vaccines market.

The global average price of Avian Influenza Vaccines is in the decreasing trend, from 20 K USD/K doses in 2011 to 19.8 USD/K doses in 2015. With the situation of global economy, prices will be in decreasing trend in the following five years.

The classification of Avian Influenza Vaccines includes H5 Avian Influenza Vaccines, H9 Avian Influenza Vaccines and other Avian Influenza Vaccines, and the proportion of H5 Avian Influenza Vaccines in 2015 is about 73%, and the proportion is in decreasing trend from 2011 to 2015.

Avian Influenza Vaccines is widely used in Chicken, Duck & Goose and Other birds. The most proportion of Avian Influenza Vaccines is used in chicken, and the production proportion in 2015 is about 77%.

China region is the largest supplier of Avian Influenza Vaccines, with a production market share nearly 49% in 2015. Asia (Ex. China) is the second largest supplier of Avian Influenza Vaccines, enjoying production market share nearly 23% in 2015.

China is the largest consumption place, with a consumption market share nearly 45% in 2015. Following China, Asia (Ex. China) is the second largest consumption place with the consumption market share of 26%.

Market competition is intense. Merial, QYH Biotech, DHN, HVRI, CEVA, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Geographical Analysis:

Based on region, the global Avian Influenza Vaccines market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.

Key Players:

The major players that are operating in the global Avian Influenza Vaccines market are

Merial

CEVA

Zoetis

Elanco (Lohmann )

Merck Animal Health

Avimex Animal Health

Segment by Type

Type H5

Type H9

Other

Segment by Application

Chicken

Duck & Goose

Other

Competitive Landscape:

Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Avian Influenza Vaccines market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.

The report covers the following objectives:

• Proliferation and maturation of trade in the global Avian Influenza Vaccines market.

• The market share of the global Avian Influenza Vaccines market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.

• Current and future market trends that are influencing the growth opportunities and growth rate of the global Avian Influenza Vaccines market.

• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Avian Influenza Vaccines market.

レポート目次

1 Avian Influenza Vaccines Market Overview

1.1 Avian Influenza Vaccines Product Scope

1.2 Avian Influenza Vaccines Segment by Type

1.2.1 Global Avian Influenza Vaccines Sales by Type (2020-2026)

1.2.2 Type H5

1.2.3 Type H9

1.2.4 Other

1.3 Avian Influenza Vaccines Segment by Application

1.3.1 Global Avian Influenza Vaccines Sales Comparison by Application (2020-2026)

1.3.2 Chicken

1.3.3 Duck & Goose

1.3.4 Other

1.4 Avian Influenza Vaccines Market Estimates and Forecasts (2015-2026)

1.4.1 Global Avian Influenza Vaccines Sales Growth Rate (2015-2026)

1.4.2 Global Avian Influenza Vaccines Revenue and Growth Rate (2015-2026)

1.4.3 Global Avian Influenza Vaccines Price Trends (2015-2026)

1.5 Coronavirus Disease 2019 (Covid-19): Avian Influenza Vaccines Industry Impact

1.5.1 How the Covid-19 is Affecting the Avian Influenza Vaccines Industry

1.5.1.1 Avian Influenza Vaccines Business Impact Assessment – Covid-19

1.5.1.2 Supply Chain Challenges

1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products

1.5.2 Market Trends and Avian Influenza Vaccines Potential Opportunities in the COVID-19 Landscape

1.5.3 Measures / Proposal against Covid-19

1.5.3.1 Government Measures to Combat Covid-19 Impact

1.5.3.2 Proposal for Avian Influenza Vaccines Players to Combat Covid-19 Impact

2 Avian Influenza Vaccines Estimate and Forecast by Region

2.1 Global Avian Influenza Vaccines Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Avian Influenza Vaccines Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Avian Influenza Vaccines Sales Market Share by Region (2015-2020)

2.2.2 Global Avian Influenza Vaccines Revenue Market Share by Region (2015-2020)

2.3 Global Avian Influenza Vaccines Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Avian Influenza Vaccines Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Avian Influenza Vaccines Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Avian Influenza Vaccines Estimates and Projections (2015-2026)

2.4.2 Europe Avian Influenza Vaccines Estimates and Projections (2015-2026)

2.4.3 China Avian Influenza Vaccines Estimates and Projections (2015-2026)

2.4.4 Japan Avian Influenza Vaccines Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Avian Influenza Vaccines Estimates and Projections (2015-2026)

2.4.6 India Avian Influenza Vaccines Estimates and Projections (2015-2026)

3 Global Avian Influenza Vaccines Competition Landscape by Players

3.1 Global Top Avian Influenza Vaccines Players by Sales (2015-2020)

3.2 Global Top Avian Influenza Vaccines Players by Revenue (2015-2020)

3.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avian Influenza Vaccines as of 2019)

3.4 Global Avian Influenza Vaccines Average Price by Company (2015-2020)

3.5 Manufacturers Avian Influenza Vaccines Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Avian Influenza Vaccines Players (Opinion Leaders)

4 Global Avian Influenza Vaccines Market Size by Type

4.1 Global Avian Influenza Vaccines Historic Market Review by Type (2015-2020)

4.1.1 Global Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

4.1.2 Global Avian Influenza Vaccines Revenue Market Share by Type (2015-2020)

4.1.3 Global Avian Influenza Vaccines Price by Type (2014-2020)

4.2 Global Avian Influenza Vaccines Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Avian Influenza Vaccines Sales Forecast by Type (2021-2026)

4.2.2 Global Avian Influenza Vaccines Revenue Forecast by Type (2021-2026)

4.2.3 Global Avian Influenza Vaccines Price Forecast by Type (2021-2026)

5 Global Avian Influenza Vaccines Market Size by Application

5.1 Global Avian Influenza Vaccines Historic Market Review by Application (2015-2020)

5.1.1 Global Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

5.1.2 Global Avian Influenza Vaccines Revenue Market Share by Application (2015-2020)

5.1.3 Global Avian Influenza Vaccines Price by Application (2015-2020)

5.2 Global Avian Influenza Vaccines Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Avian Influenza Vaccines Sales Forecast by Application (2021-2026)

5.2.2 Global Avian Influenza Vaccines Revenue Forecast by Application (2021-2026)

5.2.3 Global Avian Influenza Vaccines Price Forecast by Application (2021-2026)

3 North America Avian Influenza Vaccines Market Facts & Figures

3.2 North America Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

3.3 North America Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

3.4 North America Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

4 Europe Avian Influenza Vaccines Market Facts & Figures

4.2 Europe Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

4.3 Europe Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

4.4 Europe Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

5 China Avian Influenza Vaccines Market Facts & Figures

5.2 China Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

5.3 China Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

5.4 China Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

6 Japan Avian Influenza Vaccines Market Facts & Figures

6.2 Japan Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

6.3 Japan Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

6.4 Japan Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

7 Southeast Asia Avian Influenza Vaccines Market Facts & Figures

7.2 Southeast Asia Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

8 India Avian Influenza Vaccines Market Facts & Figures

8.2 India Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

8.3 India Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

8.4 India Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Avian Influenza Vaccines Business

12.1 Merial

12.1.1 Merial Avian Influenza Vaccines Corporation Information

12.1.2 Merial Avian Influenza Vaccines Business Overview and Total Revenue

12.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Merial Avian Influenza Vaccines Products Offered

12.1.5 Merial Recent Development

12.2 CEVA

12.2.1 CEVA Avian Influenza Vaccines Corporation Information

12.2.2 CEVA Avian Influenza Vaccines Business Overview and Total Revenue

12.2.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)

12.2.4 CEVA Avian Influenza Vaccines Products Offered

12.2.5 CEVA Recent Development

12.3 Zoetis

12.3.1 Zoetis Avian Influenza Vaccines Corporation Information

12.3.2 Zoetis Avian Influenza Vaccines Business Overview and Total Revenue

12.3.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Zoetis Avian Influenza Vaccines Products Offered

12.3.5 Zoetis Recent Development

12.4 Elanco (Lohmann )

12.4.1 Elanco (Lohmann ) Avian Influenza Vaccines Corporation Information

12.4.2 Elanco (Lohmann ) Avian Influenza Vaccines Business Overview and Total Revenue

12.4.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Elanco (Lohmann ) Avian Influenza Vaccines Products Offered

12.4.5 Elanco (Lohmann ) Recent Development

12.5 Merck Animal Health

12.5.1 Merck Animal Health Avian Influenza Vaccines Corporation Information

12.5.2 Merck Animal Health Avian Influenza Vaccines Business Overview and Total Revenue

12.5.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Merck Animal Health Avian Influenza Vaccines Products Offered

12.5.5 Merck Animal Health Recent Development

12.6 Avimex Animal Health

12.6.1 Avimex Animal Health Avian Influenza Vaccines Corporation Information

12.6.2 Avimex Animal Health Avian Influenza Vaccines Business Overview and Total Revenue

12.6.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Avimex Animal Health Avian Influenza Vaccines Products Offered

12.6.5 Avimex Animal Health Recent Development

13 Avian Influenza Vaccines Manufacturing Cost Analysis

13.1 Avian Influenza Vaccines Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Avian Influenza Vaccines

13.4 Avian Influenza Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Avian Influenza Vaccines Distributors List

14.3 Avian Influenza Vaccines Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables

Table 1. Global Avian Influenza Vaccines Sales (M Doses) Growth Rate by Type (2020-2026)

Table 2. Global Avian Influenza Vaccines Sales (M Doses) Comparison by Application (2020-2026)

Table 3. COVID-19 Impact Global Market: (Four Avian Influenza Vaccines Market Size Forecast Scenarios)

Table 4. Opportunities and Trends for Avian Influenza Vaccines Players in the COVID-19 Landscape

Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis

Table 6. Key Regions/Countries Measures against Covid-19 Impact

Table 7. Proposal for Avian Influenza Vaccines Players to Combat Covid-19 Impact

Table 8. Global Market Avian Influenza Vaccines Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 9. Global Avian Influenza Vaccines Sales (M Doses) by Region (2015-2020)

Table 10. Global Avian Influenza Vaccines Sales Market Share by Region (2015-2020)

Table 11. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Region (2015-2020))

Table 12. Global Avian Influenza Vaccines Revenue Share by Region (2015-2020)

Table 13. Global Avian Influenza Vaccines Sales (M Doses) Forecast by Region (2021-2026)

Table 14. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2021-2026)

Table 15. Global Avian Influenza Vaccines Revenue (US$ Million) Forecast by Region (2021-2026)

Table 16. Global Avian Influenza Vaccines Revenue Share Forecast by Region (2021-2026)

Table 17. Global Avian Influenza Vaccines (M Doses) of Key Companies (2015-2020)

Table 18. Global Avian Influenza Vaccines Sales Share by Company (2015-2020)

Table 19. Global Avian Influenza Vaccines Revenue (US$ Million) by Company (2015-2020)

Table 20. Global Avian Influenza Vaccines Revenue Share by Company (2015-2020)

Table 21. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avian Influenza Vaccines as of 2019)

Table 22. Global Avian Influenza Vaccines Average Price (USD/K Doses) of Key Company (2015-2020)

Table 23. Manufacturers Avian Influenza Vaccines Manufacturing Sites and Area Served

Table 24. Manufacturers Avian Influenza Vaccines Product Type

Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 26. Main Points Interviewed from Key Avian Influenza Vaccines Players

Table 27. Global Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020)

Table 28. Global Avian Influenza Vaccines Sales Share by Type (2015-2020)

Table 29. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Type (2015-2020)

Table 30. Global Avian Influenza Vaccines Price (M Doses) by Type (2015-2020)

Table 31. Global Avian Influenza Vaccines Sales Share by Type (2021-2026)

Table 32. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Type (2021-2026)

Table 33. Global Avian Influenza Vaccines Revenue Share by Type (2021-2026)

Table 34. Global Avian Influenza Vaccines Price (M Doses) by Type (2021-2026)

Table 35. Global Avian Influenza Vaccines Sales (M Doses) by Application (2015-2020)

Table 36. Global Avian Influenza Vaccines Sales Share by Application (2015-2020)

Table 37. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Application (2015-2020)

Table 38. Global Avian Influenza Vaccines Price (M Doses) by Application (2015-2020)

Table 39. Global Avian Influenza Vaccines Sales (M Doses) by Application (2021-2026)

Table 40. Global Avian Influenza Vaccines Sales Share by Application (2021-2026)

Table 41. Global Avian Influenza Vaccines Revenue (US$ Million) Market Share by Application (2021-2026)

Table 42. Global Avian Influenza Vaccines Revenue Share by Application (2021-2026)

Table 43. Global Avian Influenza Vaccines Price (M Doses) by Application (2021-2026)

Table 44. United States Avian Influenza Vaccines Sales (M Doses) by Company (2015-2020)

Table 45. United States Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

Table 46. United States Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020)

Table 47. United States Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

Table 48. United States Avian Influenza Vaccines Sales (M Doses) by Application (2015-2020)

Table 49. United States Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

Table 50. Europe Avian Influenza Vaccines Sales (M Doses) by Company (2015-2020)

Table 51. Europe Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

Table 52. Europe Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020)

Table 53. Europe Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

Table 54. Europe Avian Influenza Vaccines Sales (M Doses) by Application (2015-2020)

Table 55. Europe Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

Table 56. China Avian Influenza Vaccines Sales (M Doses) by Company (2015-2020)

Table 57. China Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

Table 58. China Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020)

Table 59. China Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

Table 60. China Avian Influenza Vaccines Sales (M Doses) by Application (2015-2020)

Table 61. China Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

Table 62. Japan Avian Influenza Vaccines Sales (M Doses) by Company (2015-2020)

Table 63. Japan Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

Table 64. Japan Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020)

Table 65. Japan Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

Table 66. Japan Avian Influenza Vaccines Sales (M Doses) by Application (2015-2020)

Table 67. Japan Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

Table 68. Southeast Asia Avian Influenza Vaccines Sales (M Doses) by Company (2015-2020)

Table 69. Southeast Asia Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

Table 70. Southeast Asia Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020)

Table 71. Southeast Asia Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

Table 72. Southeast Asia Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020)

Table 73. Southeast Asia Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

Table 74. India Avian Influenza Vaccines Sales (M Doses) by Company (2015-2020)

Table 75. India Avian Influenza Vaccines Sales Market Share by Company (2015-2020)

Table 76. India Avian Influenza Vaccines Sales (M Doses) by Type (2015-2020)

Table 77. India Avian Influenza Vaccines Sales Market Share by Type (2015-2020)

Table 78. India Avian Influenza Vaccines Sales (M Doses) by Application (2015-2020)

Table 79. India Avian Influenza Vaccines Sales Market Share by Application (2015-2020)

Table 80. Merial Corporation Information

Table 81. Merial Description and Business Overview

Table 82. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)

Table 83. Merial Avian Influenza Vaccines Product

Table 84. Merial Recent Development

Table 85. CEVA Corporation Information

Table 86. CEVA Description and Business Overview

Table 87. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)

Table 88. CEVA Avian Influenza Vaccines Product

Table 89. CEVA Recent Development

Table 90. Zoetis Corporation Information

Table 91. Zoetis Description and Business Overview

Table 92. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)

Table 93. Zoetis Avian Influenza Vaccines Product

Table 94. Zoetis Recent Development

Table 95. Elanco (Lohmann ) Corporation Information

Table 96. Elanco (Lohmann ) Description and Business Overview

Table 97. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)

Table 98. Elanco (Lohmann ) Avian Influenza Vaccines Product

Table 99. Elanco (Lohmann ) Recent Development

Table 100. Merck Animal Health Corporation Information

Table 101. Merck Animal Health Description and Business Overview

Table 102. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)

Table 103. Merck Animal Health Avian Influenza Vaccines Product

Table 104. Merck Animal Health Recent Development

Table . Avimex Animal Health Corporation Information

Table . Avimex Animal Health Description and Business Overview

Table . Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/K Doses) and Gross Margin (2015-2020)

Table . Avimex Animal Health Avian Influenza Vaccines Product

Table . Avimex Animal Health Recent Development

Table 110. Production Base and Market Concentration Rate of Raw Material

Table 111. Key Suppliers of Raw Materials

Table 112. Avian Influenza Vaccines Distributors List

Table 113. Avian Influenza Vaccines Customers List

Table 114. Market Key Trends

Table 115. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 116. Key Challenges

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Figures

Figure 1. Avian Influenza Vaccines Product Picture

Figure 2. Global Avian Influenza Vaccines Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Avian Influenza Vaccines Market Share by Application in 2020 & 2026

Figure 6. Chicken Examples

Figure 7. Duck & Goose Examples

Figure 8. Other Examples

Figure 9. Global Avian Influenza Vaccines Sales (M Doses) Growth Rate (2015-2026)

Figure 10. Global Avian Influenza Vaccines Revenue (US$ Million) Growth Rate (2015-2026)

Figure 11. Global Avian Influenza Vaccines Price Trends Growth Rate (2015-2026) (USD/K Doses)

Figure 12. Global Avian Influenza Vaccines Revenue Market Share by Region: 2015 VS 2020

Figure 13. Global Avian Influenza Vaccines Revenue Market Share by Region: 2021 VS 2026

Figure 14. United States Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2015-2026)

Figure 15. United States Avian Influenza Vaccines Sales (M Doses) Growth Rate (2015-2026)

Figure 16. Europe Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2015-2026)

Figure 17. Europe Avian Influenza Vaccines Sales (Million USD) Growth Rate (2015-2026)

Figure 18. China Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2015-2026)

Figure 19. China Avian Influenza Vaccines Sales (Million USD) and Growth Rate (2015-2026)

Figure 20. Japan Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2015-2026)

Figure 21. Japan Avian Influenza Vaccines Sales (Million USD) Growth Rate (2015-2026)

Figure 22. Southeast Asia Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2015-2026)

Figure 23. Southeast Asia Avian Influenza Vaccines Sales (Million USD) Growth Rate (2015-2026)

Figure 24. India Avian Influenza Vaccines Revenue (Million USD) Growth Rate (2015-2026)

Figure 25. India Avian Influenza Vaccines Sales (Million USD) Growth Rate (2015-2026)

Figure 26. Global 5 Largest Avian Influenza Vaccines Players Market Share by Revenue in Avian Influenza Vaccines 2015 & 2019

Figure 27. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 28. Global Avian Influenza Vaccines Revenue Share by Type (2015-2020)

Figure 29. Global Avian Influenza Vaccines Revenue Growth Rate by Type in 2015 & 2019

Figure 30. Global Avian Influenza Vaccines Revenue Share by Application (2015-2020)

Figure 31. Global Avian Influenza Vaccines Revenue Growth Rate by Application in 2015 & 2019

Figure 32. United States Avian Influenza Vaccines Sales Market Share by Type in 2019

Figure 33. United States Avian Influenza Vaccines Sales Market Share by Type in 2019

Figure 34. Europe Avian Influenza Vaccines Sales Market Share by Company in 2019

Figure 35. Europe Avian Influenza Vaccines Sales Market Share by Type in 2019

Figure 36. Europe Avian Influenza Vaccines Sales Market Share by Application in 2019

Figure 37. China Avian Influenza Vaccines Sales Market Share by Company in 2019

Figure 38. China Avian Influenza Vaccines Sales Market Share by Type in 2019

Figure 39. China Avian Influenza Vaccines Sales Market Share by Application in 2019

Figure 40. Japan Avian Influenza Vaccines Sales Market Share by Company in 2019

Figure 41. Japan Avian Influenza Vaccines Sales Market Share by Type in 2019

Figure 42. Japan Avian Influenza Vaccines Sales Market Share by Application in 2019

Figure 43. Southeast Asia Avian Influenza Vaccines Sales Market Share by Company in 2019

Figure 44. Southeast Asia Avian Influenza Vaccines Sales Market Share by Type in 2019

Figure 45. Southeast Asia Avian Influenza Vaccines Sales Market Share by Application in 2019

Figure 46. India Avian Influenza Vaccines Sales Market Share by Company in 2019

Figure 47. India Avian Influenza Vaccines Sales Market Share by Type in 2019

Figure 48. India Avian Influenza Vaccines Sales Market Share by Application in 2019

Figure 49. Merial Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. CEVA Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Elanco (Lohmann ) Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Merck Animal Health Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. Avimex Animal Health Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Key Raw Materials Price Trend

Figure 56. Manufacturing Cost Structure of Avian Influenza Vaccines

Figure 57. Manufacturing Process Analysis of Avian Influenza Vaccines

Figure 58. Avian Influenza Vaccines Industrial Chain Analysis

Figure 59. Channels of Distribution

Figure 60. Distributors Profiles

Figure 61. Porter's Five Forces Analysis

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed